Trial Profile
Phase 2 trial of Sinovac's Sabin-inactivated poliovirus vaccine in China
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 03 Dec 2016
Price :
$35
*
At a glance
- Drugs Poliovirus vaccine Intravacc/WHO (Primary)
- Indications Poliomyelitis
- Focus Therapeutic Use
- 28 Nov 2016 According to a Sinovac Biotech media release, status changed from planning to recruiting.
- 08 Nov 2016 New trial record
- 19 Oct 2016 According to Sinovac Biotech media release , this clinical trial is expected to be completed in the third quarter of 2017.